Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Bayer/CSIRO/GRDC ink wheat deal

Bayer CropScience and two Australian research organisations, the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the Grains Research and Development Corporation (GRDC), have signed a partnership deal to develop high yield wheat using genetic modification. CSIRO has been working to develop improved yield wheat varieties for several years. Earlier this year, it was given permission by the Australian Office of the Gene Technology Regulator to trial 95 GM wheat lines modified for improved nitrogen use efficiency ( Agrow No 636, p17). In greenhouse trials, CSIRO’s enhanced yield trait boosted yields by up to 30%, the partners point out. Vegetative growth is more vigorous and seed heads and seed size is increased, says CSIRO. Initial research funding has been supplied by the GRDC and the CSIRO. Bayer will now join them to support the next stage of development. The company wants to establish a globally leading wheat seed business based on a broad pool of breeding material and local varieties and focusing on outstanding agronomic properties, it notes.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts